James Reinstein Cutera CEO Rating

Cutera CEO James Reinstein Bio

Mr. James A. Reinstein has been Chief Executive Officer, President and Director of Cutera, Inc., since January 9, 2017. Mr. Reinstein is General Partner at Palo Alto Medtech Advisors. Mr. Reinstein served as the Chief Executive Officer and President of Aptus Endosystems, Inc. since 2012 until 2015. He served as the Chief Executive Officer of Drawbridge Health Inc., a joint venture of GE Ventures and GE Healthcare. Mr. Reinstein served as the Chief Commercial Officer and Senior Vice President of LivaNova PLC (also known as Cyberonics Inc.) until April 27, 2012. He served as the Vice President of Sales & Marketing and General Manager of International of LivaNova PLC since August 6, 2007. He led the sales and marketing effort in the United States and General Manager of Cyberonics Europe SA with responsibility for all sales and distribution outside the United States. As the general manager of the Epilepsy franchise at Cyberonics, he led the development of its strategic direction. At LivaNova PLC, he led a commercial turn around by growing revenues from approximately $100 million in 2007 to over $200 million within four years. He joined LivaNova PLC in 1990. He spent four years in sales and sales management roles with Proctor and Gamble. He has a long and successful track record of growing revenues and profits, the United States, Europe, Latin America and Asia with the Boston Scientific Corporation for 17 years. He served as Vice President and Regional Head of an Asian business unit at Boston Scientific Corporation and served as its European Head for its Neurovascular Division and Vice President of Boston Scientific Asia, building effective global teams and introducing new products for market leadership. He served executive positions in sales, marketing and senior management in where he led the Korean team and had responsibility for Taiwan and Hong Kong. He served as Country Director of Boston Scientific Mexico, where he built a new management team to turn around that country from 1990 to 2007. He previously held positions at Boston Scientific that included Inter-Continental Director of Marketing, European Group Marketing Manager, European Product Manager and U.S. marketing management and sales. He had 17-year career at Boston Scientific. He built strong teams within those operations with solid competencies in sales, marketing, government affairs, reimbursement, logistics and finance. Prior to joining Boston Scientific, Mr. Reinstein spent 4 years with Procter and Gamble. He has served as an Asian Advisor to the U.S. Trade Representatives negotiating the Korean-USA Free Trade Agreement. He has been a Director of Monteris Medical, Inc. since August 11, 2015. He has been Independent Director of Pixium Vision SA since June 2015. He has been an Independent Non-Executive Director at Mainstay Medical International plc since June 2015. He served as Director at Aptus Endosystems, Inc., until 2015. Mr. Reinstein was the Chairman of American Chamber of Commerce Medical Device Committee in Korea. He is a Charter Board Member of the International Society for Pharmaco economics and Outcomes Research Asia-Pacific. Mr. Reinstein received his Bachelor's degree in Business Administration from Terry College of Business at University of Georgia and Completed the Executive Management Program at INSEAD in France in 1999.

Cutera CEO James Reinstein At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Cutera.

Based on 5 ratings, James Reinstein ranks right below Allergan's CEO, Brenton Saunders.

Overall, the CEO score has remained stable over the last 90 days.